Certech partnered with Sil’Innov, a R&D company specialised in silica-based products, on the development of a patented process for the production of mesoporous silica using spray drying and a natural surfactant. An industrial process has been established and validated based on these pilot results. Mesoporosil® (trademark from Eytelia) is now available and relies on this ingredient, while various formulations enable an increase in the amount of the bioavailable silicium, in the form of orthosilicic acid, after ingestion (https://www.eytelia.eu/mesoporosil). Since the 70s, it has been proven that a lack of silicium leads to an abnormal formation of the bones as well as of the cartilaginous tissues. These issues can be solved by using soluble silica as a dietary supplement. From now on, with the development of Mesoporosil®, a new soluble, absorbable and bioavailable source of silicium – and for the first time in the solid state – is available on the market. These new ingredients are formulated into oral dosage forms (tablets, sachets, capsules) being commercialised in the new product lines INNOVASIL® and SILXPERT®, commercialised by Eytelia.